semaglutide shaky Novo Nordisk's Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US Ozempic for Weight Loss (Semaglutide)

The mean rate of eGFR decline was -1.4 per year in the combined tirzepatide groups and -3.6 per year in the insulin group (between-group difference 2.2 [95% CI 1.6 to 2.8]) with a greater benefit in participants with eGFR 500mg/dl the use of bile acid sequestrants is contraindicated (424)

Can you stay on a lower dose instead of escalating to 12mg

L-

Additional medical conditions The BMI and lifestyle requirements are both non-negotiable for Wegovy coverage, but on top of that, patients must meet one of the following requirements: Other weight loss drugs on the VA formularylike naltrexone/bupropionmust not be tolerated, not successful (less than 5% weight reduction), or medically inadvisable (with rationale)